Abstract:Vascular calcification (VC) is the ectopic deposition of calcium-containing apatite within vascular walls, exhibiting a high prevalence in older adults, and those with diabetes or chronic kidney disease. VC is a subclinical cardiovascular risk trait that increases mortality and functional deterioration. However, effective treatments for VC remain largely unavailable despite multiple attempts. Part of this therapeutic nihilism results from the failure to appreciate the diversity of VC as a pathological complex, with unforeseeable variations in morphology, risk associates, and anatomical and molecular pathogenesis, affecting clinical management strategies. VC should not be considered a homogeneous pathology because accumulating evidence refutes its conceptual and content uniformity. Here, we summarize the pathophysiological sources of VC heterogeneity from the intersecting pathways and networks of cellular, subcellular, and molecular crosstalk. Part of these pathological connections are synergistic or mutually antagonistic. We then introduce clinical implications related to the VC heterogeneity concept. Even within the same individual, a specific artery may exhibit the strongest tendency for calcification compared with other arteries. The prognostic value of VC may only be detectable with a detailed characterization of calcification morphology and features. VC heterogeneity is also evident, as VC risk factors vary between different arterial segments and layers. Therefore, diagnostic and screening strategies for VC may be improved based on VC heterogeneity, including the use of radiomics. Finally, pursuing a homogeneous treatment strategy is discouraged and we suggest a more rational approach by diversifying the treatment spectrum. This may greatly benefit subsequent efforts to identify effective VC therapeutics.

Where do we stand on vascular calcification?

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

An update on vascular calcification and potential therapeutics

Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities

Vascular calcification: Molecular mechanisms and therapeutic interventions

Vascular Calcification: A Passive Process That Requires Active Inhibition

[Vascular Calcification - Pathological Mechanism and Clinical Application - . Role of vascular smooth muscle cells in vascular calcification]

Vascular Calcification: In Vitro Models under the Magnifying Glass

Vascular Calcification—New Insights into Its Mechanism

Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon?

Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization.

Vascular Calcification Heterogeneity from Bench to Bedside: Implications for Manifestations, Pathogenesis, and Treatment Considerations

Vascular Calcification: Where is the Cure?

Vascular Calcification: New Insights into Endothelial Cells

Contributions of the Endothelium to Vascular Calcification

Vascular Calcification in Chronic Kidney Disease: An Update and Perspective

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects

Role of Macrophages in the Progression and Regression of Vascular Calcification

Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein

Recent progress in the treatment of vascular calcification

The pathophysiology and management of vascular calcification in chronic kidney disease patients